Summary
E. I. du Pont de Nemours and Company (DuPont) announced significant changes to its Board of Directors effective February 5, 2015. Two directors, Curtis J. Crawford and Richard H. Brown, resigned to pursue leadership roles at The Chemours Company, a planned spin-off from DuPont. Notably, Mr. Brown is slated to become non-executive chairman of Chemours post-separation. Concurrently, DuPont appointed two new directors, Edward D. Breen and James L. Gallogly, to its Board. This strategic board refreshment comes ahead of the anticipated separation of Chemours, suggesting a focus on leadership transition and potential new strategic directions for both entities. Investors should monitor the roles Mr. Breen and Mr. Gallogly will assume on DuPont's board and committees, as well as the future strategic implications for DuPont following the Chemours spin-off.
Key Highlights
- 1Curtis J. Crawford and Richard H. Brown resigned from the DuPont Board of Directors, effective February 5, 2015.
- 2Messrs. Crawford and Brown will transition to consultant roles and then directors at The Chemours Company upon its separation from DuPont.
- 3Richard H. Brown is expected to serve as non-executive chairman of The Chemours Company after the separation.
- 4Edward D. Breen and James L. Gallogly were appointed as new directors to the DuPont Board, effective February 5, 2015.
- 5No arrangements or understandings exist with the newly appointed directors regarding their election.
- 6The newly appointed directors will receive standard director compensation.
- 7The filing is also noting the intent to solicit materials under Rule 14a-12 of the Exchange Act.